Private equity buyers pay premiums specifically for OB/GYN practices with integrated ancillary services. That premium exists because the services generate real margin – but each one carries compliance requirements that are not optional and not uniform across states.
Key Takeaways
- In-office ultrasound, laboratory services, and elective wellness are the three ancillary lines most frequently cited in OB/GYN practice valuations – private equity buyers pay explicit premiums for practices where these services are already integrated.
- In-office ultrasound revenue is real but requires documentation of medical necessity, prior authorization compliance, and equipment maintenance logs – the most common denial driver is inadequate necessity documentation, not coding errors.
- OB/GYN genetic and routine laboratory services billed under CLIA-compliant in-office or reference arrangements must meet federal anti-markup rules and Stark Law requirements; the compliance structure must be in place before the billing starts.
- Elective wellness services – hormone replacement therapy, aesthetic procedures, sexual wellness – are largely cash-pay and carry few insurance billing complications, but scope-of-practice law, informed consent requirements, and state advertising rules apply and vary.
Obstetrics and gynecology is a specialty with a natural platform for ancillary services. The patient relationship is longitudinal, the clinical touch points are regular, and the scope of practice spans prenatal care, delivery, well-woman care, gynecologic procedures, and increasingly wellness medicine. Private equity groups have recognized this for several years – industry analysis from 2025 and 2026 explicitly identifies practices with integrated ancillary services, including in-office ultrasound, laboratory, aesthetics, and hormone therapy, as commanding higher acquisition multiples. That premium exists because the services are real contributors to practice margin. But building them correctly requires more than a capital expenditure and a billing setup. Each ancillary line has its own compliance profile, and the exposure from doing it wrong is disproportionate to the revenue at stake.
Three lines dominate the OB/GYN ancillary landscape for private practices: in-office ultrasound and diagnostic imaging, laboratory services, and elective wellness offerings. They differ significantly in their capital requirements, compliance structure, and the management attention they require to run profitably. This article addresses each in sequence.
In-Office Ultrasound: The Most Common and the Most Audited
In-office ultrasound is the most widely implemented ancillary service in OB/GYN and also the most audited by commercial payers. The clinical rationale is strong: obstetric ultrasound is medically necessary for most patients, the technology has become reliable and relatively affordable, and performing the study in the office rather than at a hospital or imaging center improves patient convenience and generates professional and technical component revenue for the practice.
The revenue is real. Depending on your payer mix and fee schedule, obstetric ultrasound reimbursement across professional and technical components can represent meaningful per-visit incremental revenue. The exposure is also real. The most common denial driver on ultrasound claims is not a coding error – it is inadequate documentation of medical necessity. Payers request records on ultrasound claims at higher rates than on most OB/GYN services, and the review standard is whether the clinical note substantiates why the specific study was performed on that date. A note that says “routine OB ultrasound” does not meet that standard for most payers. A note that documents gestational age, the specific clinical question being evaluated, and the findings addresses it.
Prior authorization requirements for ultrasound have tightened significantly among commercial payers over the past two years. Practices that do not have a consistent authorization workflow for non-routine studies – growth assessments, anatomy surveys performed outside gestational age windows, additional studies in the third trimester – will collect denials at a rate that erodes the margin the service was supposed to generate. The authorization workflow, not the imaging equipment, is the constraint that determines whether ultrasound is profitable.
The ultrasound machine generates the revenue. The authorization and documentation workflow determines whether you keep it. Most practices that are losing money on in-office imaging have a workflow problem, not an equipment problem.
Laboratory Services: The Compliance Infrastructure Matters More Than the Margin
OB/GYN practices order substantial laboratory services: prenatal panels, genetic screening, sexually transmitted infection testing, Pap processing, and pelvic cultures, among others. Capturing the technical revenue from those services – rather than referring all of them to an external laboratory – is conceptually straightforward and operationally complex.
The first question is CLIA certification. Performing laboratory tests in-office requires CLIA compliance at the appropriate certificate level for the complexity of tests being run. Many OB/GYN practices already hold a CLIA waiver for point-of-care testing such as pregnancy tests and glucose; performing more complex tests requires a higher certificate level and the accompanying quality control and proficiency testing requirements.
The second question is Stark Law and the anti-markup rule. For physicians who refer laboratory work to a laboratory they have an ownership interest in, or that is under common ownership with the practice, the Stark Law’s in-office ancillary services exception and CMS’s anti-markup rule both apply. These are not informal guidelines – they govern what can be billed, at what markup, and under what supervision structure. The compliance analysis should precede the business decision, not follow it. Rules vary and evolve, and state law adds an additional layer in some jurisdictions; independent legal review is appropriate before any ownership-based laboratory arrangement is launched.
Reference laboratory arrangements – where the practice sends specimens to a contracted reference lab and receives a portion of the technical fee – are simpler from a CLIA standpoint but raise their own markup and disclosure questions. Both models can work. Neither works without the compliance structure built in advance of billing.
Elective Wellness: High Margin, Different Risk Profile
Elective wellness services – hormone replacement therapy, aesthetic procedures such as laser treatment and body contouring, sexual wellness services, and medically supervised weight management – have become an increasing revenue focus for OB/GYN practices, particularly those with an established well-woman patient population and a physician with interest in the clinical area. The financial appeal is real: these services are predominantly cash-pay, they carry no prior authorization burden, and the margin structure is fundamentally different from insurance-driven obstetric revenue.
The risk profile is also different. Scope-of-practice law governs whether specific procedures can be performed in an office setting without anesthesia backup or additional credentialing. Advertising standards for non-insurance services vary by state, and claims about outcomes or efficacy can implicate FTC rules in addition to state medical board guidelines. Informed consent requirements for aesthetic procedures, and the documentation that backs them up, are more detailed than for routine gynecologic care. None of these are prohibitive obstacles, but they require practice-specific legal review before a service line is launched – not after a patient complaint triggers a review.
From the Field
A two-physician OB/GYN practice in the Mountain West had purchased ultrasound equipment eighteen months earlier and was frustrated that it had not generated the revenue they projected. The ultrasound was being performed and documented, but the denial rate on non-routine studies was running at 34 percent. An audit of denied claims showed the same pattern on almost every one: the clinical note did not document a specific clinical question, and prior authorization had not been obtained for studies ordered outside the standard gestational windows. Rather than produce a coding guidance document, our fractional COO engagement rebuilt the authorization workflow from scratch – mapping which study types required prior auth by payer, building a same-day authorization tracking log, and retraining the MA team on the documentation language that met each major payer’s medical necessity standard. The engagement also sat with the billing coordinator weekly for eight weeks while the new workflow settled. The denial rate on ultrasound claims fell to under 8 percent within three months, recovering more revenue in the first quarter than the equipment had cost.
Sequencing the Investment
OB/GYN practices that want to build ancillary revenue lines should sequence the investment in the order that matches their compliance readiness, not the order that reflects the revenue they most want. In-office ultrasound is typically first because the compliance framework is clearest and the clinical workflow is most natural. Laboratory services follow only after the CLIA and Stark analysis is done and the billing infrastructure is built. Elective wellness services are added when the practice has physician bandwidth, interest, and a patient population that will convert – not as an income replacement for declining insurance revenue.
Capital is not the binding constraint in most cases. Workflow and compliance are. A practice that launches a service line without the documentation and authorization workflows to support it will discover the exposure in the denial rate, and by the time the denial rate is visible, the practice has already billed for and collected revenue that may need to be returned. The order of operations – compliance structure first, billing setup second, service launch third – sounds slow but is far cheaper than the reverse.
Advice Versus Execution in Ancillary Build-Out
A consultant can produce the compliance analysis, the revenue model, and the implementation plan for any of these service lines. If your practice has an administrator who can own the execution – managing the CLIA certification process, building the authorization workflows, overseeing the vendor contracting – consulting is likely the right engagement, and it is often more economical for practices with that capacity. We scope work that way when it fits, and we tell you directly when it does.
The gap we see most often is a practice where the administrator is fully occupied with daily operations and the physicians do not have time to manage a parallel build-out project. The ancillary service gets launched at 70 percent of the required infrastructure, performs below projections, and is quietly abandoned eighteen months later. A fractional executive engagement builds the infrastructure inside the practice with your staff, working through the workflows rather than handing them over. The label “fractional executive” is unregulated, so confirm what you are actually buying – a deliverable you execute, or a person who executes it with you. That distinction matters more than any title on the engagement letter.
Sources
- FOCUS Investment Banking, OB/GYN Practice Valuation Ranges: 2026 — https://focusbankers.com/obgyn-practice-valuation/
- PhyTest, Genetic Lab Billing Services for OB/GYN Revenue — https://phytest.com/genetic-lab-billing-services-for-ob-gyn-revenue/
- CMS, Calendar Year 2026 Physician Fee Schedule Final Rule (CMS-1807-F) — https://www.cms.gov/medicare/payment/fee-schedules/physician
- MGMA, 2024 Provider Compensation and Productivity Data Report (based on 2023 data) — https://www.mgma.com/getkaiasset/252744ee-c63b-4a96-9211-8a5d6b908b39/MGMA-2024-Provider-Compensation-Data-Report.pdf
More in the OB/GYN Series
- Global Obstetric Billing and Where the Revenue Leaks — the documentation scaffold under the global obstetric package and where it quietly collapses
- Call Coverage, Staffing Models, and the Economics of Physician Burnout — what call coverage actually costs and how to model the staffing arrangements that stop the bleed
- Managing Professional Liability Cost in an Obstetric Practice — what actually drives OB/GYN malpractice premium cost and the operational steps that move it
- Migrating Gynecologic Procedures to the Office and Building the Service Line — what office-based procedure migration actually requires and where the economics break down without the right infrastructure